510(k) K810625
K810625 is an FDA 510(k) premarket notification submitted by Serono Laboratories, Inc. for the device "HUMAN PLACENTAL LACTOGEN RADIOIMMUNO-". The FDA issued a decision of Substantially Equivalent on March 27, 1981. The device falls under product code DHI (Ng3m(Bo), Antigen, Antiserum, Control), a Class I device regulated under 21 CFR 866.5065. Serono Laboratories, Inc. has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 27, 1981
- Date Received
- March 9, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Ng3m(Bo), Antigen, Antiserum, Control
- Device Class
- Class I
- Regulation Number
- 866.5065
- Review Panel
- IM
- Submission Type